Diagnostic Center | October 13, 2022
Jacobio Pharma to collaborate with Merck on clinical trial of JAB-21822
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.